Medizinische Universität Graz - Research portal
Selected Publication:
Klein, W; Eber, B; Fruhwald, F.
Is it necessary to treat silent myocardial ischemia?
ACTA MED AUST. 1992; 19(3): 67-69.
Doi: 10.1111/j.1600-051X.1992.tb01152.x
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Fruhwald Friedrich
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- At the present time there is no firm evidence that silent myocardial ischemia (on exercise or Holter ECG) should be treated with anti-ischemic drugs. Silent ischemic episodes obviously are a marker for ischemic activity of coronary artery disease and therefore a bad prognostic sign. However, antianginal drugs (nitrates, calcium-blockers, beta-blockers) have not been shown to improve prognosis. Patients with ischemic episodes should be further evaluated by thallium scintigraphy and coronary angiography. If a significant coronary disease is present, the established therapy with risk factor reduction, lipid lowering drugs and aspirin should be administered. In some instances PTCA or CABG may be indicated.
- Find related publications in this database (using NLM MeSH Indexing)
- Angina Pectoris - mortality
- Angioplasty, Transluminal, Percutaneous Coronary - mortality
- Aspirin - administration and dosage
- Cause of Death - administration and dosage
- Coronary Artery Bypass - administration and dosage
- Coronary Circulation - drug effects
- Electrocardiography, Ambulatory - drug effects
- Humans - drug effects
- Myocardial Ischemia - mortality
- Quality of Life - mortality
- Risk Factors - mortality
- Find related publications in this database (Keywords)
- Silent Myocardial Ischemia
- Nitrates
- Calcium Antagonists
- Beta-Blockers